费诺纤维酸改善盐敏感高血压通过改善脏代谢平衡
Pengfei Yang1, Mingxiao Liu2, Yuchen Li1
1Xi'an Jiaotong University, Xi'an, China.
Clinical science (London, England : 1979)
|February 19, 2026
概括
纤维酸,PPARα激活剂,通过改善代谢,氧化合成和抗氧化能力,有效地治疗雄性大鼠的盐敏感高血压 (SSH). 这为SSH提供了一个有前途的治疗策略,特别是在高脂质男性中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 盐敏感高血压 (SSH) 是一种复杂的疾病,治疗选择有限.
- 男性的SSH通常与脂质不良症相关,特别是高甘油三.
- 氧酶增殖器激活受体α (PPARα) 激活剂正在探索用于SSH治疗.
研究的目的:
- 为了研究费诺纤维酸盐的治疗潜力,PPARα激活剂,在盐敏感高血压.
- 阐明 fenofibrate 影响 SSH 的潜在机制.
- 评估纤维酸对代谢,氧化合成和氧化应激的影响.
主要方法:
- 对于盐敏感性 (SS) 的雄性达尔大鼠,在四周的时间内,给予了费诺纤维酸盐 (100 mg/kg/天).
- 监测了高盐饮食 (HSD) 诱导的高血压,脂质失调和损伤.
- 进行了脏非向代谢和分子分析 (PPARα,PPARγ,eNOS表达).
主要成果:
- 费诺纤维酸预防HSD诱导的高血压,脂质障碍和损伤,而不会影响体重.
- 代谢学揭示了纤维酸逆转了氨基酸代谢,TCA循环和氨酸生物合成中的HSD诱导的变化.
- 纤维酸提升了脏PPARα和PPARγ的调节,通过eNOS增强了氧化 (NO) 的合成,改善了氧化还原平衡,并提高了细胞能量负荷.
结论:
- 纤维酸改善SSH通过恢复脏代谢平衡,增强NO合成,减少氧化应激.
- 该药物改善了脏的生物能量,突出了其在SSH治疗中的潜力.
- 费诺纤维酸对SSH具有前景,特别是在患有高脂血症的男性患者中.
更多相关视频
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
774
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.8K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
01:30Heart Failure V: Medical Management
388
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
388
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.4K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.4K
01:16Antihypertensive Drugs: Action of Diuretics
2.5K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K